Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C346
http://purl.obolibrary.org/obo/NCIT_C346
|
|---|---|
| Preferred Name | Glucarpidase |
| Definitions |
A zinc-dependent enzyme isolated from a strain of the bacterium Pseudomonas. Because glucarpidase rapidly hydrolyzes methotrexate into inactive metabolites, it may be useful as a rescue agent for methotrexate-induced nephrotoxicity. In antibody-directed enzyme prodrug therapy (ADEPT), this agent is conjugated with an antibody that binds to a specific tumor cell type, allowing for glucarpidase-catalyzed activation of a co-administered prodrug at the site of the tumor.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A zinc-dependent enzyme isolated from a strain of the bacterium Pseudomonas. Because glucarpidase rapidly hydrolyzes methotrexate into inactive metabolites, it may be useful as a rescue agent for methotrexate-induced nephrotoxicity. In antibody-directed enzyme prodrug therapy (ADEPT), this agent is conjugated with an antibody that binds to a specific tumor cell type, allowing for glucarpidase-catalyzed activation of a co-administered prodrug at the site of the tumor. |
|---|---|
| prefLabel | Glucarpidase
|
| label | Glucarpidase
|
| PDQ_Closed_Trial_Search_ID | 41665
|
| code | C346
|
| Has_Target | |
| prefixIRI | NCIT:C346
|
| in_subset |
See more
See less
|
| Display_Name | Glucarpidase
|
| Preferred_Name | Glucarpidase
|
| FDA_UNII_Code | 2GFP9BJD79
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C20H20O4
|
| Maps_To | Glucarpidase
|
| CAS_Registry | 9074-87-7
|
| NSC Number |
641273
732443
|
| NCI_Drug_Dictionary_ID | 41665
|
| Legacy Concept Name | Carboxypeptidase-G2
|
| type | |
| ALT_DEFINITION | A bacterial enzyme that breaks down proteins and other substances, including methotrexate. It is being studied in the treatment of toxic effects caused by methotrexate. It may also help activate certain drugs to kill cancer cells. It is a type of chemoprotective agent and a type of prodrug activator.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 41665
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C0007072
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |